Image

Global Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Human leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market, By Product and Services (Instruments, Reagents and Consumables, Software and Services), Application (Diagnostics and Research), End-user (Hospitals, Academic and Research Institutes), End-User (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Technology (Polymerase Chain Reaction and Next-Generation Sequencing), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

Market Analysis and Insights of Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

Data Bridge Market Research analyses that the human leukocyte antigens (HLAs) typing transplant diagnostics services market will exhibit a CAGR of around 9.45% for the forecast period of 2022-2029. Rising prevalence of chronic disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced IT healthcare technologies, rising geriatric population base around the globe and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of human leukocyte antigens (HLAs) typing transplant diagnostics services market.

Human leukocyte antigens (HLAs) typing is a medical procedure that is conducted to diagnose the compatibility of patients and donors for cord blood or bone marrow transplants.  Human leukocyte antigens (HLAs) are the proteins in the body and its testing is carried out by molecular diagnostic procedures based on DNA.   

Upsurge in the public-private funding for target research activities is one of the major factors fostering the growth of the market. Rising number of solid organ and stem cell transplantation procedures is another market growth determinant. Ever- rising technological advancement and innovation of new instruments, surging number of drug discovery activities, rise in adoption for tissue engineering and regenerative medicine applications and untapped potential of the emerging markets will further generate lucrative market growth opportunities.

However, increased costs of molecular tests will derail the market growth rate. Also, dearth of skilled medical professionals, significant gap between the number of organ donors and organs and dearth of a favourable reimbursement scenario in the developing and underdeveloped economies will further pose challenges for the market.

This human leukocyte antigens (HLAs) typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on human leukocyte antigens (HLAs) typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope and Market Size

The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product and services, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into instruments, reagents and consumables, software and services.
  • Based on application, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into diagnostics and research.
  • Based on end-user, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into hospitals, and academic and research institutes.
  • The human leukocyte antigens (HLAs) typing transplant diagnostics services market is also segmented on the basis of technology into polymerase chain reaction and next-generation sequencing. Polymerase chain reaction is further segmented into polymerase chain reaction - sequence-specific amplification (SSP), polymerase chain reaction sequence-specific oligonucleotides probes (PCR-SSOP) and polymerase chain reaction-sequencing-based typing (PCR-SBT).

Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Country Level Analysis

The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology.

The countries covered in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the human leukocyte antigens (HLAs) typing transplant diagnostics services market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, rising technological advancements in the field of transplant diagnostics and large volume of organ transplantation procedures. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector, ever-rising geriatric population base, increased adoption of innovative transplant diagnostic technologies and rising personal disposable income.

The country section of the human leukocyte antigens (HLAs) typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The human leukocyte antigens (HLAs) typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for human leukocyte antigens (HLAs) typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human leukocyte antigens (HLAs) typing transplant diagnostics services market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Share Analysis

The human leukocyte antigens (HLAs) typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to human leukocyte antigens (HLAs) typing transplant diagnostics services market.

Some of the major players operating in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Thermo Fisher Scientific Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., QIAGEN, Immucor, Inc., Bio-Rad Laboratories, Inc., Luminex Corporation., CareDx, Inc., GenDx, Voden Medical Instruments S.p.a., TBG Diagnostics Limited, ProImmune Ltd, Pacific Biosciences of California, Inc, Omixon Inc., omicX, MC Diagnostics Ltd, Integrated Gulf Biosystems, InGen and Hologic, Inc., among others.


SKU-

Why Choose Us


Frequently Asked Questions